Anest. intenziv. Med. 2016;27(6):358-363

Management of sepsis-induced disseminated intravascular coagulopathy using antithrombin and heparin, and the use of thromboelastometry in establishing the diagnosis of heparin resistanceIntesive Care Medicine - Case Report

M. Durila1,*, P. Salaj2, H. Součková3, M. Astraverkhava1, J. Beroušek1
1 Klinika anesteziologie, resuscitace a intenzivní medicíny, 2. LF UK a FN Motol, Praha
2 Ústav hematologie a krevní tranfuze, Centrum pro trombózu a hemostázu, Praha
3 Gynekologicko-porodnická klinika, 2. LF UK a FN Motol, Praha

Severe sepsis is often accompanied by disseminated intravascular coagulation (DIC) and multiple organ dysfunction. Increased activation of coagulation is characteristic for this syndrome and therefore, from the pathophysiological point of view, it would be logical to intervene at the initiation of coagulation by the administration of antithrombin and heparin. Evidence from randomized studies offering clear instructions on the usage of these drugs is lacking though. In our case report we describe the management of septic DIC with antithrombin and heparin without bleeding complication. We have found that in order to stop the consumption of the coagulation blood components, it is required to maintain antithrombin levels above 90%. Because of the high risk of heparin resistance in sepsis it is appropriate to monitor the level of heparin with anti Xa with the aim of 0.5-0.6.

Keywords: antithrombin; heparin; heparin resistance; disseminated intravascular coagulation; thromboelastometry

Received: July 28, 2016; Accepted: September 16, 2016; Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Durila M, Salaj P, Součková H, Astraverkhava M, Beroušek J. Management of sepsis-induced disseminated intravascular coagulopathy using antithrombin and heparin, and the use of thromboelastometry in establishing the diagnosis of heparin resistance. Anest. intenziv. Med. 2016;27(6):358-363.
Download citation

References

  1. Levi, M., Toh, C. H., Thachil, J., Watson, H. G. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br. J. Haematol., 2009, 145, p. 24-33. Go to original source... Go to PubMed...
  2. Wada, H., Asakura, H., Okamoto, K. et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb. Res., 2010, 125, p. 6-11. Go to original source... Go to PubMed...
  3. Warren, B. L., Eid, A., Singer, P. et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA, 2001, 286, p. 1869-1878. Go to original source... Go to PubMed...
  4. Kienast, J., Juers, M., Wiedermann, C. J. et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J. Thromb. Haemost., 2006, 4, p. 90-97. Go to original source... Go to PubMed...
  5. Durila, M., Teslík, L., Astraverkhava, M., Vymazal, T. Úloha tromboelastometrie a antitrombínu v manažmente počínajúcej diseminovanej intravaskulárnej koagulopatie po peripartálnej hysterektómii. Anest. Intenziv. Med., 2016, 27, 2, p. 75-77.
  6. Pecka, M. Laboratorní monitorování antikoagulační léčby. Doporučení pro klinickou praxi. Vydáno 16.3.2006 u příležitosti konání XII. Pařízkových dní. Dostupné na www: http://www.thrombosis.cz/sources/Guidelines-Monitoring_antikoagulace_STH_III062.pdf
  7. Hirsh, J., Raschke, R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126, p. 188-203. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.